A Haemostasis partner to trust
Medirox is one of the market leaders in the Nordics among the producers of haemostasis diagnostic reagents and controls.
Medirox will merge with Nordic Biomarker
16 February 2021
We are happy to announce that as of Q1 2022 Medirox will merge with Nordic Biomarker. Our company name will be Nordic Biomarker and Medirox will remain as our strong, well-known brand name.
Abstract – The Novel Prothrombin Time (MRX PT DOAC) Assay
08 July 2020
Visit ISTH 2020, virual congress to read the whole poster: The Novel Prothrombin Time (MRX PT DOAC) Assay‐ Can Be Used to Detect Interfering DOACsin Thrombophilia Investigation. Poster no. PB0598